Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.

Viennois E, Ingersoll SA, Ayyadurai S, Zhao Y, Wang L, Zhang M, Han MK, Garg P, Xiao B, Merlin D.

Cell Mol Gastroenterol Hepatol. 2016 May;2(3):340-357.

PMID:
27458604
2.

Establishment and characterization of HROC69 - a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft.

Kuehn F, Mullins CS, Krohn M, Harnack C, Ramer R, Krämer OH, Klar E, Huehns M, Linnebacher M.

Sci Rep. 2016 Apr 18;6:24671. doi: 10.1038/srep24671.

3.

Inflammatory bowel disease associated neoplasia: A surgeon's perspective.

Althumairi AA, Lazarev MG, Gearhart SL.

World J Gastroenterol. 2016 Jan 21;22(3):961-73. doi: 10.3748/wjg.v22.i3.961. Review.

4.

Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance.

Wang ZH, Fang JY.

Gastrointest Tumors. 2014 Aug;1(3):146-54. doi: 10.1159/000365309. Epub 2014 Jul 18. Review.

5.

Colitis-associated colon cancer: Is it in your genes?

Van Der Kraak L, Gros P, Beauchemin N.

World J Gastroenterol. 2015 Nov 7;21(41):11688-99. doi: 10.3748/wjg.v21.i41.11688. Review.

6.

Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets.

Lu J, Zeng H, Liang Z, Chen L, Zhang L, Zhang H, Liu H, Jiang H, Shen B, Huang M, Geng M, Spiegel S, Luo C.

Sci Rep. 2015 Oct 8;5:14739. doi: 10.1038/srep14739.

7.

Mitochondrial dysfunction in cancer.

Księżakowska-Łakoma K, Żyła M, Wilczyński JR.

Prz Menopauzalny. 2014 May;13(2):136-44. doi: 10.5114/pm.2014.42717. Epub 2014 May 21. Review.

8.

Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia.

Horvath B, Liu G, Wu X, Lai KK, Shen B, Liu X.

Gastroenterol Rep (Oxf). 2015 Nov;3(4):344-9. doi: 10.1093/gastro/gov022. Epub 2015 Jun 10.

9.

Spatial modeling of colonic lesions with geographic information systems.

Imanieh MH, Goli A, Imanieh MH, Geramizadeh B.

Iran Red Crescent Med J. 2014 Dec 27;17(1):e18129. doi: 10.5812/ircmj.18129. eCollection 2015 Jan.

PMID:
25763265
Free PMC Article
10.

Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.

de Vries AB, Janse M, Blokzijl H, Weersma RK.

World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956. Review.

11.

Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.

Kuehn F, Klar E, Bliemeister A, Linnebacher M.

World J Gastroenterol. 2015 Jan 7;21(1):221-8. doi: 10.3748/wjg.v21.i1.221.

12.

Oxidative stress and its significant roles in neurodegenerative diseases and cancer.

Thanan R, Oikawa S, Hiraku Y, Ohnishi S, Ma N, Pinlaor S, Yongvanit P, Kawanishi S, Murata M.

Int J Mol Sci. 2014 Dec 24;16(1):193-217. doi: 10.3390/ijms16010193. Review.

13.

Ulcerative colitis-associated colorectal cancer.

Yashiro M.

World J Gastroenterol. 2014 Nov 28;20(44):16389-97. doi: 10.3748/wjg.v20.i44.16389. Review.

14.

Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease.

Myers JN, Schäffer MW, Korolkova OY, Williams AD, Gangula PR, MʼKoma AE.

Inflamm Bowel Dis. 2014 Sep;20(9):1530-47. doi: 10.1097/MIB.0000000000000144.

15.

Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases.

Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP.

Clin Gastroenterol Hepatol. 2015 Feb;13(2):322-329.e1. doi: 10.1016/j.cgh.2014.07.018. Epub 2014 Jul 17.

16.

Does the prognosis of colorectal cancer vary with tumor site?

Jafarabadi MA, Mohammadi SM, Hajizadeh E, Kazemnejad A, Fatemi SR.

Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):199-209.

17.

Inflammatory bowel disease: an expanding global health problem.

M'Koma AE.

Clin Med Insights Gastroenterol. 2013 Aug 14;6:33-47. doi: 10.4137/CGast.S12731. eCollection 2013. Review.

18.

Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer.

Liang X, Li H, Tian G, Li S.

Sci Rep. 2014 May 15;4:4985. doi: 10.1038/srep04985.

19.

Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines.

Hernández V, Clofent J.

Ann Gastroenterol. 2012;25(3):193-200. Review.

20.

Advanced therapeutic endoscopist and inflammatory bowel disease: dawn of a new role.

Modha K, Navaneethan U.

World J Gastroenterol. 2014 Apr 7;20(13):3485-94. doi: 10.3748/wjg.v20.i13.3485. Review.

Items per page

Supplemental Content

Write to the Help Desk